A Phase I C Clinical Study With Influenza Antiviral DAS181-F03: Double-Blind, Randomized, Placebo-Controlled, Single Dose and Multiple Dose Escalation Study in Healthy Adults.

Trial Profile

A Phase I C Clinical Study With Influenza Antiviral DAS181-F03: Double-Blind, Randomized, Placebo-Controlled, Single Dose and Multiple Dose Escalation Study in Healthy Adults.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jul 2013

At a glance

  • Drugs DAS 181 (Primary)
  • Indications Influenza A virus H1N1 subtype; Influenza virus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Mar 2012 Planned End Date changed from 1 Oct 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 19 May 2011 Planned End Date changed from 1 Mar 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
    • 07 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top